Ads
related to: severe asthma exacerbation
Search results
What to Know About Severe Asthma in Kids
Time via Yahoo News· 2 years agoCredit - Carlos Andres—Getty Images Asthma isn’t always a quick and easy diagnosis in children. According to a 2014 task force assembled by the American...
Pre-med student: Poor air quality makes asthma harder on Black, Hispanic kids
The Florida Times-Union via Yahoo News· 1 year agoAsthma exacerbation is on the rise for Hispanic school-aged children. Indoor air quality needs to be...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 1 month agoAstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 1 week agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Many Asthma Patients Don’t Follow Their Medication Plans. Here’s How to Change That
Time via Yahoo News· 1 year agoCredit - Karl Tapales—Getty Images In 2017, an expert commission organized by the Lancet examined...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 1 week agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
The #1 Thing to Do If You're Having an Asthma Attack and Don't Have Your Inhaler, According to...
Parade via Yahoo News· 23 hours agoWoman having asthma attack without inhaler When you have asthma, you likely know that you shouldn’t...
7 Surprising Asthma Triggers to Know About
GQ via Yahoo News· 3 weeks agoGetty Images; Gabe Conte During an asthma attack, the airways responsible for bringing fresh oxygen into the body become inflamed. The muscles in the...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 1 week agoGSK has announced positive data from two Phase III trials of its asthma candidate depemokimab. The pharma giant announced the drug met primary endpoints...
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Motley Fool· 1 year agoLast month, British drugmaker AstraZeneca (NASDAQ: AZN) received good news from the U.S. Food and...
